EGFR and urothelial carcinoma: More recently, an analysis of 3753 urothelial carcinoma cases identified one case of an EGFR del19 mutation and three cases of EGFR L858R mutations, all of which affect the tyrosine kinase domain (TKD), with additional cases of exon 20 insertions (27 cases) [39].